Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 11/20 | 0.55 |
| ▸ | MGAM | O43451 | 10/20 | 0.55 |
| ▸ | AMY1A | P0DUB6 | 10/20 | 0.55 |
| ▸ | SI | P14410 | 10/20 | 0.55 |
| ▸ | MGAM2 | Q2M2H8 | 10/20 | 0.55 |
| ▸ | F2 | P00734 | 2/20 | 0.55 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | MITF | O75030 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23780256 | 0.91 | KMT2A (0.62) | KMT2AALDH1A1MEN1HPGDHSD17B10 | |
| SCHEMBL535030 | 0.89 | ASAH1 (0.64) | KMT2AALDH1A1MEN1HPGDHSD17B10 | |
| SCHEMBL18206302 | 0.88 | ASAH1 (0.66) | KMT2AALDH1A1MEN1HPGDHSD17B10 | |
| SCHEMBL534984 | 0.88 | ASAH1 (0.66) | KMT2AALDH1A1MEN1HPGDHSD17B10 | |
| SCHEMBL5793440 | 0.88 | ASAH1 (0.66) | KMT2AALDH1A1MEN1HPGDHSD17B10 | |
| SCHEMBL534899 | 0.88 | ASAH1 (0.66) | KMT2AALDH1A1MEN1HPGDHSD17B10 | |
| SCHEMBL535029 | 0.88 | ASAH1 (0.66) | KMT2AALDH1A1MEN1HPGDHSD17B10 | |
| SCHEMBL337266 | 0.88 | ASAH1 (0.66) | KMT2AALDH1A1MEN1HPGDHSD17B10 | |
| SCHEMBL535094 | 0.88 | ASAH1 (0.66) | KMT2AALDH1A1MEN1HPGDHSD17B10 | |
| SCHEMBL13134139 | 0.87 | GAA (0.58) | KMT2AALDH1A1HPGDHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250186433-A1 | ACSS2 INHIBITORS AND METHODS OF USE THEREOF | EPIVARIO, INC. | 2025-06-12 | — | — | US | disclosed |
| US-12133852-B2 | ACSS2 inhibitors and methods of use thereof | EPIVARIO, INC. (US) | 2024-11-05 | — | — | US | disclosed |
| US-20230102379-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | POINT LOMA NAZARENE UNIVERSITY | 2023-03-30 | — | — | US | disclosed |
| US-20220305010-A1 | ACSS2 INHIBITORS AND METHODS OF USE THEREOF | METABOMED LTD. (IL) | 2022-09-29 | — | — | US | disclosed |
| CN-114008025-A | ACSS2 inhibitors and methods of use thereof | 美特波米德有限公司 | 2022-02-01 | — | — | CN | disclosed |
| WO-2021150951-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-07-29 | — | — | WO | disclosed |
| WO-2021150951-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-07-29 | — | — | WO | disclosed |
| WO-2020230136-A1 | ACSS2 INHIBITORS AND METHODS OF USE THEREOF | METABOMED LTD (IL) | 2020-11-19 | — | — | WO | disclosed |
| EP-1952918-B1 | METHOD FOR PRODUCING METAL PARTICLE DISPERSION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM | TOYO INK MFG CO (JP) | 2013-05-22 | — | — | EP | disclosed |
| US-8440110-B2 | Method for producing metal particle dispersion, conductive ink using metal particle dispersion produced by such method, and conductive coating film | TOYO INK MFG CO., LTD. (JP) | 2013-05-14 | — | — | US | disclosed |
| EP-1990377-B1 | COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION CONTAINING SAID COLORED METALLIC PIGMENT | TOYO ALUMINIUM KK (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-7998266-B2 | Colored metallic pigment, process for producing the same, and coating composition and cosmetic preparation containing said colored metallic pigment | TOYO ALUMINIUM KABUSHIKI KAISHA (JP) | 2011-08-16 | — | — | US | disclosed |
| US-20110175040-A1 | METHOD FOR PRODUCING METAL PARTICLE DISPRESION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM | TOYO INK MFG CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-7981327-B2 | Method for producing metal particle dispersion, conductive ink using metal particle dispersion produced by such method, and conductive coating film | TOYO INK MFG. CO. LTD. (JP) | 2011-07-19 | — | — | US | disclosed |
| US-20090258202-A1 | Method for Producing Metal Particle Dispersion, Conductive Ink Using Metal Particle Dispersion Produced by Such Method, and Conductive Coating Film | GVP GESELLSCHAFT ZUR VERMARKTUNG DER PORENBRENNERTECHNIK MBH (DE) | 2009-10-15 | — | — | US | disclosed |
| US-20090017082-A1 | COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION CONTAINING SAID COLORED METALLIC PIGMENT | TOYO ALUMINIUM KABUSHIKI KAISHA (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1990377-A1 | COLORED METALLIC PIGMENT, PROCESS FOR PRODUCING THE SAME, AND COATING COMPOSITION AND COSMETIC PREPARATION COMPRISING SAID COLORED METALLIC PIGMENT | TOYO ALUMINIUM KABUSHIKI KAISHA (JP) | 2008-11-12 | — | — | EP | disclosed |
| EP-1952918-A1 | METHOD FOR PRODUCING METAL PARTICLE DISPERSION, CONDUCTIVE INK USING METAL PARTICLE DISPERSION PRODUCED BY SUCH METHOD, AND CONDUCTIVE COATING FILM | Toyo Ink Mfg. Co., Ltd (JP) | 2008-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230102379-A1 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | LSS, REL, RPN1 | KMT2A 2885/4885ALDH1A1 1897/4885MEN1 3542/4885 |
| US-20250186433-A1 | ACSS2 INHIBITORS AND METHODS OF USE THEREOF | ACSS2, GLS2, ADSS2 | KMT2A 1401/4885ALDH1A1 238/4885MEN1 1305/4885 |
| US-20220305010-A1 | ACSS2 INHIBITORS AND METHODS OF USE THEREOF | ACSS2, GLS2, ADSS2 | KMT2A 1401/4885ALDH1A1 238/4885MEN1 1305/4885 |
| US-12133852-B2 | ACSS2 inhibitors and methods of use thereof | ACSS2, GLS2, ADSS2 | KMT2A 1401/4885ALDH1A1 238/4885MEN1 1305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.